慢性主髂动脉闭塞性疾病腔内治疗后股浅动脉与股深动脉对保肢的重要性
本研究回顾2008年1月至2016年7月在巴西圣保罗州公务员医院血管与腔内血管外科接受主髂动脉血管成形术的慢性主髂动脉闭塞性疾病患者,按患肢流出道为仅股深动脉(第1组)或股深动脉加股浅动脉(第2组)分组,比较无截肢生存、通畅率与总生存率。结果显示股浅动脉通畅与否不影响腔内治疗结局,仅经股深动脉加腘动脉流出者的通畅率、生存率和保肢率与双流出道者相似。
要点
- 仅股深动脉加腘动脉作为流出道时,1800天保肢率与双流出道相似(91.3% vs 86.1%,P = .60)。
- 股浅动脉闭塞未影响保肢率:单因素分析P = .509,多因素Cox回归分析P = .671。
- 1800天一期与二期通畅率两组相似(80.2% vs 82.3%,P = .80;84.7% vs 97.6%,P = .10)。
核心结论
- 股浅动脉的通畅与否不干扰慢性主髂动脉闭塞性疾病腔内治疗的结局。
- 以股深动脉加腘动脉作为髂动脉腔内治疗唯一流出道,其通畅率、生存率和保肢率与经股深动脉和股浅动脉双流出道者相似。
研究设计与样本
- 单中心研究,纳入2008年1月至2016年7月在巴西圣保罗州公务员医院血管与腔内血管外科接受主髂动脉血管成形术的慢性主髂动脉闭塞性疾病患者。
- 共69例患者行69次主髂动脉血管成形术,按患肢流出道分为仅股深动脉组(第1组,22例,31.8%)和股深动脉加股浅动脉组(第2组,47例,67.2%)。
- 主要结局为无截肢生存,次要结局为通畅率和总生存率。
主要发现
- 共行12次再干预(17.4%),第1组7次(31.8%),第2组5次(10.2%),两组间无统计学显著性(P = .063)。
- 平均临床随访2500 ± 880.5天。
- 1800天一期通畅率第1组80.2% vs 第2组82.3%(P = .80),二期通畅率第1组84.7% vs 第2组97.6%(P = .10)。
- 1800天保肢率第1组91.3% vs 第2组86.1%(P = .60),生存率第1组74.7% vs 第2组78%(P = .80)。
- Bollinger评分第1组更差(P = .001),符合股浅动脉闭塞的预期;股深动脉与腘动脉评分两组相似。
关键数值与推荐
- 单因素分析显示股浅动脉闭塞未影响保肢率(P = .509)。
- 多因素Cox回归分析显示股浅动脉闭塞未影响保肢率(P = .671)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to report the long-term limb salvage, survival and patency rates of endovascular treatment for aortoiliac occlusive disease (AIOD) when outflow was achieved through the profunda femoris artery (PFA) only vs both the PFA and superficial femoral artery (SFA). METHODS: From January 2008 to July 2016, patients with AIOD who underwent aortoiliac angioplasty at the Division of Vascular and Endovascular Surgery, Hospital do Servidor Público Estadual, São Paulo, Brazil, were classified into two groups according to whether they had femoral outflow via the PFA only (group 1) or both the PFA and SFA (group 2) in the affected leg. The primary outcome was amputation-free survival. The secondary outcomes were the patency and overall survival rates. RESULTS: In total, 69 aortoiliac angioplasties were performed in 69 patients: 22 patients (31.8%) in group 1 and 47 (67.2%) in group 2. A total of 12 reinterventions (17.4%) were performed, seven (31.8%) in group 1 and five (10.2%) in group 2, without statistical significance between the groups (P = .063). The mean clinical follow-up period was 2500 ± 880.5 days. Both the primary and secondary patency rates analyzed at 1800 days were similar between groups 1 and 2 (80.2% vs 82.3%; P = .80 and 84.7% vs 97.6%; P = .10, respectively). Furthermore, the limb salvage rates at 1800 days were similar between groups 1 and 2 (91.3% vs 86.1%; P = .60), as were the survival rates (74.7% vs 78%; P = .80). The Bollinger score was worse in group 1 (P = .001), as expected, because of occlusion of the SFA. However, the PFA and popliteal artery scores were similar between the two groups. Occlusion of the SFA did not influence the limb salvage rate according to univariate analysis (P = .509) and multivariate Cox regression analysis (P = .671). CONCLUSIONS: The patency of the SFA does not interfere with the outcomes of endovascular treatment for chronic AIOD. The PFA in conjunction with the popliteal artery as the sole outflow route for iliac endovascular treatment is associated with similar patency, survival, and limb salvage rates as those for outflow through both the PFA and SFA.
引用
- de Athayde Soares R, Matielo MF, Brochado Neto FC, et al. The importance of the superficial and profunda femoris arteries in limb salvage following endovascular treatment of chronic aortoiliac occlusive disease. J Vasc Surg. 2018. PMID: 29804745. doi:10.1016/j.jvs.2018.02.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。